61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A net income 2002–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Genmab A/S ADS earned 342.00M USD in Q3 FY2026, the three months to 30 September 2026, down 14.7% on the same quarter a year before. Genmab A/S ADS's net income over the last twelve months was 729.10M USD, down 84.2% on the twelve months before. In fiscal year 2025 it earned 963.76M USD, down 87.7% on the year before.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
Net income
Net income · +2.4% a year over 10 yearsNet margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 729.10M | -84.19% | 16.97% | 4.30B |
| FY2025 | 31 Dec 2025 | 963.76M | -87.71% | 25.89% | 3.72B |
| FY2024 | 31 Dec 2024 | 7.84B | +80.24% | 36.44% | 21.53B |
| FY2023 | 31 Dec 2023 | 4.35B | -20.18% | 26.42% | 16.47B |
| FY2022 | 31 Dec 2022 | 5.45B | +84.38% | 37.59% | 14.51B |
| FY2021 | 31 Dec 2021 | 2.96B | -37.85% | 35.13% | 8.42B |
| FY2020 | 31 Dec 2020 | 4.76B | +119.67% | 47.06% | 10.11B |
| FY2019 | 31 Dec 2019 | 2.17B | +47.13% | 40.37% | 5.37B |
| FY2018 | 31 Dec 2018 | 1.47B | +33.40% | 48.66% | 3.03B |
| FY2017 | 31 Dec 2017 | 1.10B | -7.04% | 46.65% | 2.37B |
| FY2016 | 31 Dec 2016 | 1.19B | +55.48% | 65.36% | 1.82B |
| FY2015 | 31 Dec 2015 | 763.51M | +153.41% | 67.39% | 1.13B |
| FY2014 | 31 Dec 2014 | 301.30M | +168.15% | 35.43% | 850.39M |
| FY2013 | 31 Dec 2013 | 112.36M | — | 16.93% | 663.57M |
| FY2012 | 31 Dec 2012 | -487.12M | — | -100.51% | 484.64M |
| FY2011 | 31 Dec 2011 | -596.37M | — | -169.94% | 350.94M |
| FY2010 | 31 Dec 2010 | -321.46M | — | -55.23% | 582.08M |
| FY2009 | 31 Dec 2009 | -1.01B | — | -172.46% | 586.08M |
| FY2008 | 31 Dec 2008 | -965.09M | — | -139.40% | 692.30M |
| FY2007 | 31 Dec 2007 | -383.37M | — | -72.40% | 529.54M |
| FY2006 | 31 Dec 2006 | -438.24M | — | -323.31% | 135.55M |
| FY2005 | 31 Dec 2005 | -393.59M | — | -399.56% | 98.51M |
| FY2004 | 31 Dec 2004 | -415.21M | — | -10,124.65% | 4.10M |
| FY2003 | 31 Dec 2003 | -327.11M | — | -478.75% | 68.33M |
| FY2002 | 31 Dec 2002 | -479.33M | — | — | 0.00 |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 342.00M | -14.71% | 28.81% | 1.19B |
| Q2 FY2026 | 30 Jun 2026 | 303.00M | -9.80% | 26.23% | 1.16B |
| Q1 FY2026 | 31 Mar 2026 | 53.20M | +85.35% | 5.92% | 899.32M |
| Q4 FY2025 | 31 Dec 2025 | 30.91M | -99.20% | 2.93% | 1.05B |
| Q3 FY2025 | 30 Sept 2025 | 401.00M | -68.33% | 39.24% | 1.02B |
| Q2 FY2025 | 30 Jun 2025 | 335.93M | +65.48% | 36.32% | 924.81M |
| Q1 FY2025 | 31 Mar 2025 | 28.70M | -85.05% | 27.27% | 105.23M |
| Q4 FY2024 | 31 Dec 2024 | 3.85B | +500.78% | 59.70% | 6.44B |
| Q3 FY2024 | 30 Sept 2024 | 1.27B | -39.83% | 22.85% | 5.54B |
| Q2 FY2024 | 30 Jun 2024 | 203.00M | -84.79% | 3.76% | 5.40B |
| Q1 FY2024 | 31 Mar 2024 | 192.00M | -8.57% | 31.84% | 603.00M |
| Q4 FY2023 | 31 Dec 2023 | 640.00M | +24.51% | 13.68% | 4.68B |
| Q3 FY2023 | 30 Sept 2023 | 2.10B | -18.51% | 44.65% | 4.71B |
| Q2 FY2023 | 30 Jun 2023 | 1.34B | -29.40% | 32.02% | 4.17B |
| Q1 FY2023 | 31 Mar 2023 | 210.00M | -54.84% | 7.41% | 2.83B |
| Q4 FY2022 | 31 Dec 2022 | 514.00M | -28.21% | 10.01% | 5.14B |
| Q3 FY2022 | 30 Sept 2022 | 2.58B | +190.11% | 63.18% | 4.09B |
| Q2 FY2022 | 30 Jun 2022 | 1.89B | +517.97% | 59.80% | 3.16B |
| Q1 FY2022 | 31 Mar 2022 | 465.00M | -57.57% | 21.94% | 2.12B |
| Q4 FY2021 | 31 Dec 2021 | 716.00M | +23.24% | 27.34% | 2.62B |
| Q3 FY2021 | 30 Sept 2021 | 890.00M | +67.92% | 38.53% | 2.31B |
| Q2 FY2021 | 30 Jun 2021 | 306.00M | -90.94% | 15.52% | 1.97B |
| Q1 FY2021 | 31 Mar 2021 | 1.10B | +307.43% | 69.32% | 1.58B |
| Q4 FY2020 | 31 Dec 2020 | 581.00M | -60.53% | 28.42% | 2.04B |
| Q3 FY2020 | 30 Sept 2020 | 530.00M | -1.30% | 30.74% | 1.72B |
| Q2 FY2020 | 30 Jun 2020 | 3.38B | +3,874.12% | 61.97% | 5.45B |
| Q1 FY2020 | 31 Mar 2020 | 269.00M | +273.61% | 30.16% | 892.00M |
| Q4 FY2019 | 31 Dec 2019 | 1.47B | +76.51% | 49.70% | 2.96B |
| Q3 FY2019 | 30 Sept 2019 | 537.00M | +199.71% | 51.64% | 1.04B |
| Q2 FY2019 | 30 Jun 2019 | 85.00M | -67.37% | 10.98% | 773.91M |
| Q1 FY2019 | 31 Mar 2019 | 72.00M | -63.74% | 12.18% | 591.01M |
| Q4 FY2018 | 31 Dec 2018 | 833.87M | +6.11% | 67.47% | 1.24B |
| Q3 FY2018 | 30 Sept 2018 | 179.18M | — | 29.93% | 598.60M |
| Q2 FY2018 | 30 Jun 2018 | 260.53M | -15.21% | 51.12% | 509.68M |
| Q1 FY2018 | 31 Mar 2018 | 198.57M | +1,133.46% | 29.16% | 681.01M |
| Q4 FY2017 | 31 Dec 2017 | 785.87M | -6.60% | 77.21% | 1.02B |
| Q3 FY2017 | 30 Sept 2017 | -5.68M | -103.01% | -1.76% | 323.45M |
| Q2 FY2017 | 30 Jun 2017 | 307.27M | +82.65% | 39.73% | 773.35M |
| Q1 FY2017 | 31 Mar 2017 | 16.10M | — | 6.42% | 250.78M |
| Q4 FY2016 | 31 Dec 2016 | 841.41M | +116.04% | 90.72% | 927.46M |
| Q3 FY2016 | 30 Sept 2016 | 188.96M | +34.71% | 51.82% | 364.66M |
| Q2 FY2016 | 30 Jun 2016 | 168.23M | +920.26% | 47.55% | 353.83M |
| Q1 FY2016 | 31 Mar 2016 | -11.53M | -105.30% | -6.77% | 170.17M |
| Q4 FY2015 | 31 Dec 2015 | 389.47M | +464.26% | 67.77% | 574.66M |
| Q3 FY2015 | 30 Sept 2015 | 140.27M | -12.29% | 50.50% | 277.77M |
| Q2 FY2015 | 30 Jun 2015 | 16.49M | — | 9.49% | 173.84M |
| Q1 FY2015 | 31 Mar 2015 | 217.29M | +120.60% | 203.50% | 106.78M |
| Q4 FY2014 | 31 Dec 2014 | 69.02M | +15.29% | 31.98% | 215.80M |
| Q3 FY2014 | 30 Sept 2014 | 159.92M | +2,893.11% | 58.90% | 271.52M |
| Q2 FY2014 | 30 Jun 2014 | -26.15M | — | -22.55% | 115.99M |
| Q1 FY2014 | 31 Mar 2014 | 98.50M | +35.88% | 39.87% | 247.07M |
| Q4 FY2013 | 31 Dec 2013 | 59.87M | — | 27.71% | 216.04M |
| Q3 FY2013 | 30 Sept 2013 | 5.34M | — | 3.57% | 149.66M |
| Q2 FY2013 | 30 Jun 2013 | -25.34M | — | -18.35% | 138.09M |
| Q1 FY2013 | 31 Mar 2013 | 72.49M | — | 45.37% | 159.78M |
| Q4 FY2012 | 31 Dec 2012 | -359.80M | — | -220.60% | 163.10M |
| Q3 FY2012 | 30 Sept 2012 | -55.77M | — | -48.13% | 115.88M |
| Q2 FY2012 | 30 Jun 2012 | -2.08M | — | -1.86% | 111.65M |
| Q1 FY2012 | 31 Mar 2012 | -69.48M | — | -73.90% | 94.01M |
| Q4 FY2011 | 31 Dec 2011 | -43.81M | — | -47.07% | 93.07M |
| Q3 FY2011 | 30 Sept 2011 | -360.77M | — | -397.03% | 90.87M |
| Q2 FY2011 | 30 Jun 2011 | -80.57M | — | -96.06% | 83.88M |
| Q1 FY2011 | 31 Mar 2011 | -111.22M | — | -133.80% | 83.12M |
| Q4 FY2010 | 31 Dec 2010 | -83.91M | — | -92.04% | 91.16M |
| Q3 FY2010 | 30 Sept 2010 | -18.45M | — | -8.60% | 214.60M |
| Q2 FY2010 | 30 Jun 2010 | -88.69M | — | -52.23% | 169.80M |
| Q1 FY2010 | 31 Mar 2010 | -130.41M | — | -122.43% | 106.52M |
| Q4 FY2009 | 31 Dec 2009 | -607.61M | — | -314.99% | 192.90M |
| Q3 FY2009 | 30 Sept 2009 | -89.55M | — | -129.73% | 69.03M |
| Q2 FY2009 | 30 Jun 2009 | -114.45M | — | -154.30% | 74.17M |
| Q1 FY2009 | 31 Mar 2009 | -199.16M | — | -79.67% | 249.98M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Genmab A's profit
Source: Financial Modeling Prep